935106861
info@markelab.com
Precio
375€ (100 µg)
Sutimlimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting C1S, Sutimlimab is an anti-C1s antibody. Studies have shown that it can significantly increase hemoglobin levels in patients with primary cold agglutinin disease. Cold agglutinin disease (CAD) is a type of acquired autoimmune hemolytic anemia (AIHA). In cold environments, cold parts of the body will have clinical symptoms related to red blood cell aggregation (for example, the Internet Plaque or cyanosis) and hemolytic anemia.
Biosimilars
Human
Monoclonal
Human
C1S
Human
IgG4 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 2049079-64-1
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más